NHS Blood and Transplant Clinical Biotechnology Centre implements the Amperia system to streamline viral vector process development for novel gene therapies The NHSBT Clinical Biotechnology Centre (CBC), Bristol, one of three government selected Innovation Hubs tasked...
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development
Collaborative Project to Develop Next-Generation Cell Platform for Viral Vector Production Receives £1.1 Million Grant from Innovate UK & NRC.